MediaZest plc (AIM:MDZ)

Checkpoint Therapeutics Income Statement

Financials in millions GBP. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Revenue	3.81	3.07	2.34	2.82	2.25	2.05
Revenue Growth (YoY)	55.13%	31.65%	-17.20%	25.56%	9.81%	-14.67%
Cost of Revenue	1.79	1.48	1.07	1.32	1.17	1.03
Gross Profit	2.02	1.6	1.26	1.5	1.08	1.02
Selling, General & Admin	1.87	1.66	1.55	1.34	1	1.16
Other Operating Expenses	-	-	-	-	-	-0.02
Operating Expenses	1.89	1.66	1.55	1.34	1.07	1.22
Operating Income	0.14	-0.06	-0.29	0.16	0	-0.21
Interest Expense	-0.16	-0.15	-0.16	-0.15	-0.14	-0.11
EBT Excluding Unusual Items	-0.01	-0.21	-0.46	0.01	-0.14	-0.32
Other Unusual Items	-	-	-0.1	-	-	-
Pretax Income	-0.01	-0.21	-0.55	0.01	-0.14	-0.32
Income Tax Expense	0.01	0	-	-	-	-0.02
Net Income	-0.02	-0.21	-0.55	0.01	-0.14	-0.3
Net Income to Common	-0.02	-0.21	-0.55	0.01	-0.14	-0.3
Shares Outstanding (Basic)	1,698	1,615	1,396	1,396	1,396	1,396
Shares Outstanding (Diluted)	1,698	1,615	1,396	1,396	1,396	1,396
Shares Change (YoY)	16.00%	15.66%	-	-	-	-
EPS (Basic)	-0.00	-0.00	-0.00	0.00	-0.00	-0.00
EPS (Diluted)	-0.00	-0.00	-0.00	0.00	-0.00	-0.00
Free Cash Flow	0.24	-0.14	0.12	-0.06	0.24	-0.05
Gross Margin	53.09%	51.89%	54.05%	53.16%	47.86%	49.67%
Operating Margin	3.55%	-1.95%	-12.50%	5.57%	0.18%	-10.10%
Profit Margin	-0.53%	-6.96%	-23.68%	0.43%	-6.23%	-14.60%
Free Cash Flow Margin	6.17%	-4.42%	4.92%	-2.09%	10.60%	-2.35%
EBITDA	0.22	0.01	-0.23	0.22	0.08	-
EBITDA Margin	5.88%	0.46%	-9.64%	7.80%	3.47%	-
D&A For EBITDA	0.09	0.07	0.07	0.06	0.07	-
EBIT	0.14	-0.06	-0.29	0.16	0	-0.21
EBIT Margin	3.55%	-1.95%	-12.50%	5.57%	0.18%	-10.10%

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.